[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

St. Louis Round Table - May 18, 2019

St. Louis Round Table - May 18, 2019 image

St. Louis Round Table - May 18, 2019

Roundtable
event May 18, 2019 / 09:00AM - 03:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

On May 18, 2019, a Myeloma Crowd Round Table meeting was held in St Louis, Missouri at the Eric P. Newman Education Center featuring six myeloma experts, including:

  • Dr. Robert Kyle, Mayo Clinic, Rochester, MN
  • Dr. Amrita Krishnan, City of Hope, Duarte, CA
  • Dr. Mark Schroeder, Washington University, St. Louis, MO
  • Dr. Keith Stockerl-Goldstein, Washington University, St. Louis, MO
  • Dr. Ravi Vij, Washington University, St. Louis, MO
  • Dr. Tanya Wildes, Washington University, St. Louis, MO
  • Dr. Jim Omel, Grand Island, NE

 

Thanks to our Platinum Sponsor

Thanks to our additional Myeloma Crowd Round Table Sponsors: Takeda Oncology, GSK, Celgene, Karyopharm and Adaptive Biotechnologies

 

St. Louis Round Table, May 18, 2019

MCRT Review

expand_more

Speakers & Moderators

The panelist Amrita Krishnan, M.D.
Amrita Krishnan, M.D.

Amrita Y. Krishnan completed her medical degree at Albany Medical College in New York as part of a combined BS-MD six-year accelerated program, where she was selected for the Alpha Omega Alpha Honor Medical Society. Her postdoctoral training comprised residency and internship in the Strong Memorial Hospital Department of Medicine at the University of Rochester, as well as fellowships at City of Hope Medical Center, Harvard Medical School Beth Israel Hospital, and the Dana Farber Cancer Institute. Dr. Krishnan is a Diplomate of the American Board of Hematology. She is also active in several professional societies. She is the former Chair of the American Society of Clinical Oncology plasma cell committee and former Co-Chair of the Center for International Blood and Marrow Transplant Research Plasma Cell Committee, and former Chair of the Blood and Marrow Transplant Clinical Trials Network myeloma committee and is a subcommittee member of the American Society of Hematology, American Society for Blood and Marrow Transplantation, a steering committee member for the Multiple Myeloma Research Foundation and the North American representative for the International Myeloma Foundation and is a member of the state of the science committee for ASTCT focused on defining the next generation of therapies in myeloma. Dr. Krishnan has authored almost 200 articles, abstracts, and book chapters, and she is a reviewer for several journals, including American Journal of Hematology, Bone Marrow Transplantation, Haematologica, Blood, and Biology of Blood and Marrow Transplantation. An active researcher, Dr. Krishnan was instrumental in bringing successful transplant therapy to HIV patients with lymphoma when many believed such patients were too weak to tolerate the procedure. She is currently the principal investigator of an innovative trial utilizing zinc finger nuclease–based stem cell therapy for HIV treatment. She is also the co-chair of one of the largest myeloma transplant trials in the United States evaluating the role of minimal residual disease to guide maintenance.

Read Bio
The panelist Mark Schroeder, MD
Mark Schroeder, MD

Mark Schroeder, MD, is Associate Professor of Medicine, Division of Oncology, Section of Blood and Marrow Transplantation at Washington University School of Medicine. Dr. Schroeder is a graduate of the University of Cincinnati College of Medicine and completed his residency in Internal Medicine and fellowship in Hematology and Oncology at Washington University in St. Louis. He joined faculty at Washington University in 2009. He is a member of the Siteman Cancer Center and serves on the National Comprehensive Cancer Network Hematopoietic Cell Transplant Panel. Dr. Schroeder’s clinical research focuses on multiple myeloma, graft versus host disease, and stem cell transplant biology.

Read Bio
The panelist Ravi Vij, MD, MBA
Ravi Vij, MD, MBA

Ravi Vij, MD, MBA, is Professor of Medicine at the Washington University School of Medicine in the Division of Medical Oncology, Section of Bone Marrow Transplantation and Leukemia. Dr. Vij’s primary academic interests include the treatment of hematologic malignancies and hematopoietic stem cell transplantation. He has research interests in multiple myeloma and AML/myelodysplastic syndromes. Dr. Vij serves on numerous committees including the International Myeloma Working Group (IWMG), the Core Transplant Myeloma and Leukemia Committees of the CALGB, the Steering Committee of the Multiple Myeloma Research Consortium, and the Myeloma Committee of the BMT Clinical Trials Network (CTN). His honors include the Multiple Myeloma Research Foundation Innovator Award (2013) and the Multiple Myeloma Research Consortium Center of Excellence Award (2011). He has authored more than 130 publications in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation. He has authored the book Contemporary Management of Multiple Myeloma and several chapters in books, including Multiple Myeloma and Plasma Cell Dyscrasias in the Washington Manual of Oncology. He has served as a review for journals including Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Experimental Hematology and Haematologica.

Read Bio

Location

St. Louis, MO

320 S Euclid Ave, St. Louis, MO 63110, USA

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.